sebov-detection

Prolonged-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus sickness epizootics.

Ebolavirus (EBOV) has precipitated sickness outbreaks taking tons of of lives, costing billions of {{dollars}} in administration efforts and threatening good ape populations. EBOV ecology should not be completely understood nonetheless contaminated wildlife and consumption of animal carcasses have been linked to human outbreaks, notably inside the Congo Basin.
Partnering with the Congolese Ministry of Nicely being, we carried out wildlife mortality surveillance and educational outreach inside the northern Republic of Congo (RoC). Designed for EBOV detection and to alert public properly being authorities, we established a low-cost wildlife mortality reporting group masking 50 000 km2.
Concurrently, we delivered educational outreach promoting behavioural change to over 6600 people in rural northern RoC. We achieved specimen assortment by teaching enterprise employees on a protected sampling protocol and equipping geographically distributed bases with sampling kits.
We established in-country diagnostics for EBOV testing, reducing diagnostic turnaround time to a few days and demonstrated the absence of EBOV in 58 carcasses. Central Africa stays a high-risk EBOV space, nonetheless RoC, home to crucial remaining populations of good apes, has not had an epidemic since 2005.
This effort continues to function as an untested early warning system in RoC, the place people and good apes have died from earlier Ebola virus sickness outbreaks. This textual content is part of the theme topic ‘Dynamic and integrative approaches to understanding pathogen spillover’.
sebov-detection

sebov-detection

PSMB8 Antibody

1-CSB-PA775839
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

PSMB8 Antibody

E043134 100μg/100μl
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

1-CSB-PA018886GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

PSMB8 Antibody

1-CSB-PA018886LA01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

PSMB8 Antibody

E94054 100μg
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

E97340 100ul
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

E314816 100ug/200ul
EUR 295
Description: Available in various conjugation types.

PSMB8 antibody

70R-13550 100 ul
EUR 550
Description: Affinity purified Rabbit polyclonal PSMB8 antibody

PSMB8 antibody

70R-19589 50 ul
EUR 289
Description: Rabbit polyclonal PSMB8 antibody

PSMB8 Antibody

1-CSB-PA116429
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PSMB8 antibody

BF0434 100ug
EUR 355

PSMB8 Antibody

MBS7113266-005mL 0.05mL
EUR 190

PSMB8 Antibody

MBS7113266-01mL 0.1mL
EUR 270

PSMB8 Antibody

MBS7113266-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody

MBS7129229-005mL 0.05mL
EUR 190

PSMB8 Antibody

MBS7129229-01mL 0.1mL
EUR 270

PSMB8 Antibody

MBS7129229-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody

MBS7129230-005mL 0.05mL
EUR 190

PSMB8 Antibody

MBS7129230-01mL 0.1mL
EUR 270

PSMB8 Antibody

MBS7129230-5x01mL 5x0.1mL
EUR 1205

PSMB8 antibody

MBS9405580-01mL 0.1mL
EUR 420

PSMB8 antibody

MBS9405580-5x01mL 5x0.1mL
EUR 1740

PSMB8 Antibody

MBS8500013-01mg 0.1mg
EUR 325

PSMB8 Antibody

MBS8500013-01mLAF405L 0.1mL(AF405L)
EUR 565

PSMB8 Antibody

MBS8500013-01mLAF405S 0.1mL(AF405S)
EUR 565

PSMB8 Antibody

MBS8500013-01mLAF610 0.1mL(AF610)
EUR 565

PSMB8 Antibody

MBS8500013-01mLAF635 0.1mL(AF635)
EUR 565

PSMB8 Antibody

MBS5312424-01mL 0.1mL
EUR 1070

PSMB8 Antibody

MBS5312424-5x01mL 5x0.1mL
EUR 4655

PSMB8 Antibody

MBS9416351-01mL 0.1mL
EUR 305

PSMB8 Antibody

MBS9416351-5x01mL 5x0.1mL
EUR 1230

PSMB8 Antibody

BF0434-100ul 100ul
EUR 210
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody

BF0434-200ul 200ul Ask for price
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody

BF0434-50ul 50ul
EUR 150
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Conjugated Antibody

C43134 100ul
EUR 476.4

PSMB8 Polyclonal Antibody

E-AB-92394-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-92394-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-92394-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-92394-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody

A73468 50 μl
EUR 557

PSMB8 Polyclonal Antibody

E-AB-61655-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-61655-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-61655-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody

E-AB-61655-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody

MBS2538339-006mL 0.06mL
EUR 190

PSMB8 Polyclonal Antibody

MBS2538339-012mL 0.12mL
EUR 265

PSMB8 Polyclonal Antibody

MBS2538339-02mL 0.2mL
EUR 415

PSMB8 Polyclonal Antibody

MBS2538339-5x02mL 5x0.2mL
EUR 1835

PSMB8 Polyclonal Antibody

MBS2527805-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody

MBS2527805-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody

MBS2527805-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody

MBS2527805-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody

MBS2527805-5x02mL 5x0.2mL
EUR 1725

PSMB8 Polyclonal Antibody

MBS2528965-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody

MBS2528965-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody

MBS2528965-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody

MBS2528965-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody

MBS2528965-5x02mL 5x0.2mL
EUR 1725

PSMB8 Conjugated Antibody

MBS9451453-01mLAF350 0.1mL(AF350)
EUR 480

PSMB8 Conjugated Antibody

MBS9451453-01mLAF405 0.1mL(AF405)
EUR 480

PSMB8 Conjugated Antibody

MBS9451453-01mLAF488 0.1mL(AF488)
EUR 480

PSMB8 Conjugated Antibody

MBS9451453-01mLAF555 0.1mL(AF555)
EUR 480

PSMB8 Conjugated Antibody

MBS9451453-01mLBiotin 0.1mL(Biotin)
EUR 480

PSMB8 Polyclonal Antibody

RD84433A-120uL 120μL
EUR 360
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody

RD84433A-200uL 200μL
EUR 630
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody

RD84433A-60uL 60μL
EUR 204
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Antibody (N-term)

MBS9213569-008mL 0.08mL
EUR 210

A novel carbon nanoparticle probe-based ultrasensitive lateral circulation assay for quick detection of Ebola virus.

Ebola virus (EBOV) is an terribly contagious pathogen first present in Africa associated to excessive hemorrhagic sickness in individuals and nonhuman primates, which has resulted in at least 28 500 suspected circumstances and 11 300 confirmed deaths in 2014-2016 Ebola epidemic in West Africa.
Speedy and delicate detection of EBOV is the essential factor to rising the likelihood of survival and reducing an an infection costs in pandemic areas. Proper right here, we report an ultrasensitive and instrument-free EBOV detection assay primarily based totally on colloidal carbon immunochromatography.
Carbon nanoparticle-labeled rabbit anti-EBOV-VP40 IgG had been concentrated inside the conjugate pad, monoclonal antibody (McAb, 4B7F9) in the direction of EBOV-VP40 and goat anti-rabbit IgG had been immobilized on the nitrocellulose membrane with 2 μL/cm at a spotlight of 1 mg/mL as check out and administration strains, respectively.
Then the sample software program pad, conjugate launch pad, nitrocellulose membrane and absorbent pad had been assembled proper right into a lateral circulation check out strip.
The check out strip reveals strong specificity in the direction of related viruses that share comparable medical indicators and geographic fluctuate with EBOV, along with marburg virus, influenza virus, yellow fever virus and dengue virus. In addition to, 1 500 damaging serums had been examined with false-positive value of 1.3‰ which significantly lower than that of ReEBOV™ colloidal gold check out bundle helpful by World Nicely being Group (WHO).
The sensitivity of this strip was analyzed using inactivated EBOV with detection prohibit of 100 ng/mL (10⁶ copies/mL) which clearly elevated than that of ReEBOV™ dipstick (10⁸ copies/mL). Furthermore, the strip confirmed wonderful thermal stability traits in room temperature and is likely to be as a point-of-care (POC), ultra-sensitive and specific promising candidate for EBOV serological screening in rural Africa or entry/exit ports.

A Survey of Virus Recombination Uncovers Canonical Choices of Artificial Chimeras Generated All through Deep Sequencing Library Preparation.

Chimeric reads could also be generated by in vitro recombination all through the preparation of high-throughput sequencing libraries.
Our attempt to detect natural recombination between the genomes of dengue virus (DENV; +ssRNA genome) and its mosquito host using the Illumina Nextera sequencing library preparation bundle revealed that almost all, if not all, detected host-virus chimeras had been artificial.
Definitely, these chimeras weren’t further frequent than with administration RNA from one different species (a pillbug), which was certainly not in contact with DENV RNA earlier to the library preparation.
The proportion of chimera varieties merely mirrored these of the three species amongst sequencing reads. Chimeras had been repeatedly characterised by the presence of 1-20 bp microhomology between recombining fragments.
Inside-species chimeras principally involved fragments in reverse orientations and located decrease than 100 bp from each other inside the parental genome.
We found comparable choices in printed datasets using two totally different viruses: Ebola virus (EBOV; -ssRNA genome) and a herpesvirus (dsDNA genome), every produced with the Illumina Nextera protocol. These canonical choices counsel that artificial chimeras are generated by intra-molecular template switching of the DNA polymerase all through the PCR step of the Nextera protocol.
Lastly, a broadcast Illumina dataset using the Flock Residence virus (FHV; +ssRNA genome) generated with a protocol stopping artificial recombination revealed the presence of 1-10 bp microhomology motifs in FHV-FHV chimeras, nonetheless just a few recombining fragments had been in reverse orientations.
Our analysis uncovered sequence choices characterizing recombination breakpoints in short-read sequencing datasets, which can be helpful to guage the presence and extent of artificial recombination.

Influenza A (A / Brisbane / 10 / 07) H3N2 Protein

abx060621-50g 50 µg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

7-07948 10µg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

7-07949 50µg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

7-07950 1mg Ask for price

H3N2 Influenza-A Virus Brisbane 10/07

rAP-5410 Inquiry Ask for price

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

20-abx260509
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 50 ug

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

abx260509-10g 10 µg
EUR 325

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

abx260509-2g 2 µg
EUR 225

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen

11-567 0.1 mg
EUR 632.4
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2)

Influenza A Strain A/Brisbane/10/07 (H3N2) Protein

GWB-T00035 1mg Ask for price

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

IFLUABN1007H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant

rAP-5428 Inquiry Ask for price

Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag

E40VAG023 20ug
EUR 495

H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant

rAP-5423 Inquiry Ask for price

Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag

E40VAG011 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set

ABPR-ZB267 5 plates, 15 plates Ask for price
Description: Quantitative determination of Influenza Hemagglutinin

Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag

E40VAG022 20ug
EUR 495

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-563 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-564 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza B- Virus Brisbane 60/2008 Recombinant

rAP-5434 Inquiry Ask for price

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG161 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG163 20ug
EUR 495

Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag

E40VAG010 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag

E40VAG162 20ug
EUR 495

Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag

E40VAG283 20ug
EUR 495

Rabbit Anti-IBV (Influenza B/Brisbane/60/2008) HA2 Polyclonal Antibody

CABT-CS796 100 μg
EUR 520
Description: Rabbit

Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL)

0810585CFHI 1 mL
EUR 422

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug

QP12081-10ug 10ug
EUR 186

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg

QP12081-1mg 1mg
EUR 2470.8

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug

QP12081-50ug 50ug
EUR 241.2

Recombinant (HEK) purified Influenza A nucleoprotein (H1N1-NP/1-486aa) protein (A/Brisbane/59/2007, >95%, His-tag)

H1NP26-R-25 25 ug
EUR 416.4

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)

HA1B012-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)

HA1B012-R-100 100 ug
EUR 927.6

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)

HA1B013-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)

HA1B013-R-100 100 ug
EUR 927.6

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-100 0.1
EUR 512.85
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-500 0.5
EUR 2181.53
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Brisbane 1007

iha-024 10µg
EUR 60
Description: Influenza A Virus H3N2 Brisbane 1007

IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His]

DAG1693 50 ug
EUR 2017.2

IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His]

DAG2329 100 µg
EUR 868.8

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His]

DAG2335 100 µg
EUR 868.8

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-100 0.1
EUR 512.85
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG

H3N21-M 100 ul
EUR 578.4

Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure

H3N23-A 100 ul
EUR 534

Recombinant IAV H3N2 (A/Brisbane/10/2007) Hemagglutinin [His]

DAG-H10412 100 µg
EUR 860
Description: Recombinant

IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His]

DAG2224 100 µg
EUR 1095.6

IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His]

DAG2328 100 µg
EUR 868.8

IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His]

DAG1688 50 ug
EUR 2017.2

IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His]

DAG2282 100 µg
EUR 1095.6

Rabbit Anti-IAV H3N2 (A/Brisbane/10/2007) M2 Polyclonal Antibody

CABT-CS799 100 μg
EUR 520
Description: Rabbit

IAV H1N1 Hemagglutin (aa 51-301) (A/Brisbane/59/2007) [His]

DAG2202 100 µg
EUR 1095.6

IAV H1N1 Hemagglutin (aa 18-530) (A/Brisbane/59/2007) [His]

DAG2220 100 µg
EUR 1095.6

Influenza A H3 Antibody

abx021977-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody

abx021978-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody

abx021977-400l 400 µl Ask for price

Influenza A H3 Antibody

abx021977-80l 80 µl
EUR 975

Influenza A H3 Antibody

abx021978-400l 400 µl Ask for price

Influenza A H3 Antibody

abx021978-80l 80 µl
EUR 975

Influenza B [B/Florida/02/2006] Viral Lysate

NAT41648-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]

DAG1775 50 ug
EUR 2017.2

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]

DAG2279 100 µg
EUR 1095.6

IAV H3N2 Hemagglutinin 1 (aa 17-346) (A/Brisbane/299/2011 ) [His]

DAG2246 100 µg
EUR 1095.6

Mouse Anti-IAV H3N2 (A/Brisbane/10/2007) HA Monoclonal Antibody, Clone 75E2

CABT-CS773 100 μg
EUR 645
Description: Mouse

Recombinant IAV H1N1 Protein (aa 18-530) (A/Brisbane/59/2007) [His]

VAng-Lsx0333-inquire inquire Ask for price
Description: IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His], recombinant protein from HEK 293 cells.

Influenza B [B/Massachusetts/2/2012] Viral Lysate

NAT41653-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza B [B/Massachusetts/2/2012] Viral Lysate

NAT41653-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)

VAng-Wyb7007-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)

VAng-Wyb7007-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Influenza A H3 Antigen Antibody

GWB-78ADD7 0.1 mg Ask for price

Recombinant IBV (B/Brisbane/60/2008) HA Protein

DAG-H10446 100 µg
EUR 996
Description: Recombinant

Influenza A virus H3 PCR kit

PCR-H649-48R 50T
EUR 987.6

Influenza A virus H3 PCR kit

PCR-H649-96R 100T
EUR 1335.6

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-10g 10 µg
EUR 687.6
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His]

DAG2215 100 µg
EUR 1095.6

IBV Nucleoprotein (aa 1-560) (B/Brisbane/60/2008) [His]

DAG2319 100 µg
EUR 868.8

OPPA01552-10UG - H3N2 Brisbane Protein

OPPA01552-10UG 10ug
EUR 70

Mouse Anti-IAV H1N1 (A/Brisbane/59/2007) HA Monoclonal Antibody, Clone 9G9

CABT-CS761 100 μg
EUR 645
Description: Mouse

IBV Matrix Proteins 1 (aa 1-252) (B/Brisbane/60/2008) [His]

DAG2304 100 µg
EUR 868.8

IBV Matrix Proteins 1 (aa 1-248) (B/Brisbane/60/2008) [His]

DAG2305 100 µg
EUR 868.8

Influenza A Virus H3 Antigen Antibody

abx415738-01mg 0.1 mg
EUR 861.6

Influenza A Virus H3 Antigen Antibody

abx415738-200l 200 µl
EUR 687.5

Influenza A virus H3 RT PCR kit

RTq-H649-100R 100T
EUR 1573.2

Influenza A virus H3 RT PCR kit

RTq-H649-150R 150T
EUR 2144.4